Clinical Trial Update: Efficacy of Repyflec Cognitive Remediation Group Training in Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Repyflec Cognitive Remediation Group Training in schizophrenia has completed, with results posted in August 2013.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Repyflec Cognitive Remediation Group Training

Snippet

Sponsor: Fundació Sant Joan de Déu | Conditions: Indication for Modification of Patient Cognitive Status | Phase 4 | Status: COMPLETED | Results posted: 2013-08-15